Regeneron Pharmaceuticals
S&P 500
Nasdaq 100
$973.36
+1.26%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of 0.06.
- Comfortable interest cover: operating profit covers interest about 81.7 times.
- Return on equity is moderate at 13.5%.
- Net profit margin is strong at 31.4%.
- Current assets comfortably cover current liabilities (current ratio 4.13).
!Watch-points
- Return on capital employed is on the lower side at 8.9%.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreSafe zone
9.1
In Altman’s original study, companies in this range showed a low incidence of financial distress.
Piotroski F-ScoreModerate
4 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$100.69B
Current Price$ 973.36
High / Low$ 975.49 / 591.52
Stock P/E21.515472
Book Value$ 317.22
Dividend Yield0.38%
ROCE8.94%
ROE13.45%
Debt to Equity0.06
Current Ratio4.13
P/B Ratio2.9148972
EPS$ 41.48
Debt$1.99B
PAT Margin31.41%
Cash PAT$5.05B
ICR81.69